Submissions from forbes.com/sites/leahrosenbaum

		Moderna Starts Covid-19 Vaccine Trial in Kids Younger Than 12 Years Old (forbes.com/sites/leahrosenbaum)
		5 points by grawprog on March 24, 2021 \| past
		Tempus Labs Valued at $8.1B (forbes.com/sites/leahrosenbaum)
		1 point by berkserbet on Dec 18, 2020 \| past
		Biotech Startup Hexagon Bio Just Raised $47M to Make Drugs from Fungi (forbes.com/sites/leahrosenbaum)
		2 points by finphil on Sept 15, 2020 \| past
		Why ‘T Cell Immunity’ Won’t End the Coronavirus Pandemic (forbes.com/sites/leahrosenbaum)
		1 point by tghw on Aug 20, 2020 \| past
		Machine Learning Company Insitro Raises $143M to Bridge Biology and AI (forbes.com/sites/leahrosenbaum)
		3 points by kgwgk on May 27, 2020 \| past
		Machine Learning Company Insitro Raises $143M to Bridge Biology and AI (forbes.com/sites/leahrosenbaum)
		1 point by myth_drannon on May 27, 2020 \| past
		Free text-based Covid-19 screening program (forbes.com/sites/leahrosenbaum)
		1 point by masevak on March 13, 2020 \| past \| 1 comment
		Pharma Startup EQRx Raises $200M in Funding Aims to Make Drugs Cheaper (forbes.com/sites/leahrosenbaum)
		1 point by finphil on Jan 12, 2020 \| past